BLUE bluebird bio, Inc. Projected Future Earnings

bluebird bio Inc. (BLUE) - corporate logo

bluebird bio, Inc. (BLUE) develops innovative treatments for hereditary blood disorders for patients with thalassemia. Business development relies on a strategic alliance with Resilience and insurance structures. However, the high cost of product launches is causing a liquidity deficit. The company's expected financial result on this chart demonstrates market expectations, where 0.02 shows the value of this parameter.

BLUE: bluebird bio, Inc Expected Profit 04/01/2025 - 05/16/2025

Bluebird Bio - analytical breakdowns and key metrics (BLUE)

General company analysis:bluebird bio
Core merchandise of bluebird bio Inc.

bluebird bio, Inc. (BLUE) develops breakthrough gene therapy methods, attracting leading geneticists through stock option plans and large-scale financing. This profit forecast visualizes market expectations regarding the issuer's future cash flows. The metric is based on actual session closes, measuring the trend of investors' fundamental optimism. However, excessive faith in these figures often creates an inflated share price, posing a risk of substantial losses during a correction of market valuations.

Competitor analysis for bluebird bio, Inc.

Expected Profit Tempus AI|Projected Future Earnings Qiagen|Projected Future Earnings IONS|Expected Profit RGEN (Repligen Corp.)|Avidity - Future Profit|CRSP (crisprtx.com) - Forward Earnings|WGS: Future Profit|Projected Net Profit Ultragenyx (RARE)|BEAM: Projected Future Earnings|Sarepta Therapeutics, Inc. (SRPT) - Projected Future Earnings|TWST (twistbioscience.com) - Projected Future Earnings|10x Genomics, Inc. (TXG) - Company Profit Forecast|Future Profit NTLA (Intellia Therapeutics, Inc.)|STOK - Expected Net Profit|Expected Profit biolifesolutions.com BLFS|Company Profit Forecast Wave Life Sciences Corp (WVE)|MAZE - Expected Profit|Expected Net Income SION (Sionna Therapeutics Inc)|PRME: Projected Future Earnings|Taysha - Expected Net Income|Expected Profit uniQure NV|Net Profit Forecast MGTX (MeiraGTx PLC)|Future Profit RGNX (regenxbio.com)|Solid Biosciences Inc. - Net Profit Forecast|Expected Profit Ocugen Corp OCGN|Pacific Biosciences of California, Inc. (PACB) - Expected Net Profit|BNTC - Expected Profit|Design Pharma - Future Net Profit|RCKT (Rocket Pharmaceuticals Inc) - Future Profit|4D Molecular Therapeutics (FDMT) - Projected Future Earnings|Expected Profit Lexeo Therapeutics, Inc.|Expected Net Profit Korro Bio, Inc. KRRO|Projected Future Earnings EDIT|Company Profit Forecast Silence Therapeutics Corp|Expected Profit proqr.com PRQR|CDXS - Future Profit|SGMO - Expected Profit|Projected Net Profit Nautilus Biotechnology, Inc. (NAUT)|MGX: Projected Future Earnings|Net Profit Forecast DTIL|GBIO (Generation Bio) - Projected Future Earnings|Net Profit Forecast BOLD (boundlessbio.com)|Future Profit XCUR (exicuretx.com)|Celsion Corporation - Net Profit Forecast|Projected Future Earnings PHIO (phiopharma.com)|Projected Future Earnings Mustang Bio, Inc. MBIO|RNAZ: Future Profit|BNGO (Bionano Genomics) - Net Profit Forecast|APDN: Projected Future Earnings|Net Profit Forecast IPA|OMGA (omegatherapeutics.com) - Projected Future Earnings|Singular Genomics Systems Inc (OMIC) - Company Profit Forecast|Projected Future Earnings RGLS|Company Profit Forecast Syros Pharmaceuticals, Inc.|Expected Profit Telesis Bio Inc. TBIO|Future Net Profit TCON (TRACON Pharmaceuticals Inc.)|Unity Bio - Projected Future Earnings